Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,371,791
+$2,422,559 QoQ
Shares Held
583,219
+6.5% QoQ
Ownership
0.301%
of shares outstanding
% of Portfolio
7.81%
of 13F equity value
Holder Rank
#54
of 564 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOONE CAPITAL MANAGEMENT LLC holds $221,198,549 across 10 Biotechnology names. BMRN ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
415,641 | $48,659,091 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
519,977 | $41,228,976 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
583,219 | $33,371,791 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
339,720 | $25,302,345 | |
| 5 | GLUE |
Monte Rosa Therapeutics, Inc.
|
615,287 | $14,889,945 | |
| 6 | KOD |
Kodiak Sciences Inc.
|
378,010 | $14,727,269 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
455,605 | $14,242,212 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
113,173 | $12,977,547 |
All Filings in BMRN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,371,791 | 583,219 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $30,949,232 | 547,871 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,478,028 | 411,880 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,794,051 | 328,546 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,596,271 | 447,449 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,135,352 | 327,279 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||